Wave Life Sciences Ltd. Forecast, price target & analysts
Wave Life Sciences Ltd. Target price 2025 - Analyst rating & recommendation
Wave Life Sciences Ltd. Classifications & Recommendation:
Wave Life Sciences Ltd. Price Target
| Target Price | $22.91 |
| Price | $10.56 |
| Potential |
116.94%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Wave Life Sciences Ltd. 2026 .
The average Wave Life Sciences Ltd. target price is $22.91.
This is
116.94%
register free of charge
$36.00
240.91%
register free of charge
$15.00
42.05%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Wave Life Sciences Ltd. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Wave Life Sciences Ltd. stock has an average upside potential 2026 of
116.94%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 113.31 | 54.07 |
| 3,004.38% | 52.29% | |
| EBITDA Margin | -51.88% | -273.74% |
| 98.76% | 427.60% | |
| Net Margin | -70.72% | -282.70% |
| 99.15% | 299.76% |
11 Analysts have issued a sales forecast Wave Life Sciences Ltd. 2024 . The average Wave Life Sciences Ltd. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Wave Life Sciences Ltd. 2024 . The average Wave Life Sciences Ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Wave Life Sciences Ltd. Analysts have issued a net profit forecast 2024. The average Wave Life Sciences Ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.54 | -1.03 |
| 73.66% | 90.74% | |
| P/E | negative | |
| EV/Sales | 24.69 |
5 Analysts have issued a Wave Life Sciences Ltd. forecast for earnings per share. The average Wave Life Sciences Ltd. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Wave Life Sciences Ltd. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Wave Life Sciences Ltd....
Current Wave Life Sciences Ltd. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies | Locked ➜ Locked | Locked | Feb 25 2025 |
| Mizuho | Locked ➜ Locked | Locked | Nov 21 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Nov 13 2024 |
| Truist Securities | Locked ➜ Locked | Locked | Nov 12 2024 |
| B. Riley Securities | Locked ➜ Locked | Locked | Nov 04 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Oct 31 2024 |
| RBC Capital | Locked ➜ Locked | Locked | Oct 21 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies: Locked ➜ Locked
|
Feb 25 2025 |
|
Locked
Mizuho: Locked ➜ Locked
|
Nov 21 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Nov 13 2024 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Nov 12 2024 |
|
Locked
B. Riley Securities: Locked ➜ Locked
|
Nov 04 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Oct 31 2024 |
|
Locked
RBC Capital: Locked ➜ Locked
|
Oct 21 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
